Carlos A. Gartner

2.1k total citations · 1 hit paper
25 papers, 1.7k citations indexed

About

Carlos A. Gartner is a scholar working on Molecular Biology, Cell Biology and Spectroscopy. According to data from OpenAlex, Carlos A. Gartner has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Spectroscopy. Recurrent topics in Carlos A. Gartner's work include Endoplasmic Reticulum Stress and Disease (4 papers), Analytical Chemistry and Chromatography (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Carlos A. Gartner is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Analytical Chemistry and Chromatography (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Carlos A. Gartner collaborates with scholars based in United States, Brazil and Denmark. Carlos A. Gartner's co-authors include Steven P. Gygi, David M. Valenzuela, David J. Glass, Jeffrey J. Brault, Alfred L. Goldberg, Esther Latres, Shenhav Cohen, Scott M. Wilson, Daniel Finley and Soyeon Park and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Carlos A. Gartner

23 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancement of proteasome activity by a small-molecule inhibitor of USP14

2010 760 citations Byung‐Hoon Lee, Min Jae Lee et al. Nature profile →

Peers

Countries citing papers authored by Carlos A. Gartner

Since Specialization

Citations

This map shows the geographic impact of Carlos A. Gartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos A. Gartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos A. Gartner more than expected).

Fields of papers citing papers by Carlos A. Gartner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos A. Gartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos A. Gartner. The network helps show where Carlos A. Gartner may publish in the future.

Co-authorship network of co-authors of Carlos A. Gartner

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos A. Gartner. A scholar is included among the top collaborators of Carlos A. Gartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos A. Gartner. Carlos A. Gartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The bronchoalveolar proteome changes in obesity 2025 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·William G. Tharp, Carlos A. Gartner, (unknown), Calvin Vary, S. Patrick Bender, Anne E. Dixon	0
2	Lipidomic and proteomic insights from extracellular vesicles in the postmortem dorsolateral prefrontal cortex reveal substance use disorder-induced brain changes 2025 ·Translational Psychiatry ·Chioma M. Okeoma, (unknown), (unknown), Carlos A. Gartner, (unknown), Calvin Vary, (unknown), Victor Corasolla Carregari, Martin R. Larsen, Alessio Noghero, Consuelo Walss‐Bass, Rodrigo Grassi‐Oliveira	0
3	Inhibition of acyl‐ CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction 2025 ·Molecular Oncology ·Connor Murphy, Heather Fairfield, Victoria DeMambro, (unknown), Carlos A. Gartner, (unknown), (unknown), (unknown), Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin Vary, Michaela R. Reagan	3
4	ALK1 Signaling in Human Cardiac Progenitor Cells Promotes a Pro-angiogenic Secretome 2024 ·PubMed ·(unknown), Sergey Ryzhov, Douglas B. Sawyer, Carlos A. Gartner, Calvin Vary	2
5	Exploratory Mass Spectrometry of Cerebrospinal Fluid from Persons with Autopsy-Confirmed LATE-NC 2024 ·Journal of Molecular Neuroscience ·József Gál, Calvin Vary, Carlos A. Gartner, Gregory A. Jicha, Erin L. Abner, (unknown), Ibrahim Choucair, Donna M. Wilcock, Ruth S. Nelson, Peter T. Nelson	2
6	Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells 2023 ·Frontiers in Oncology ·Heather Fairfield, (unknown), Mariah Farrell, (unknown), Carlos A. Gartner, Calvin Vary, Michaela R. Reagan	8
7	Purification of functional mouse skeletal muscle mitochondria using percoll density gradient centrifugation 2023 ·BMC Research Notes ·(unknown), Anyonya R. Guntur, Calvin Vary, Carlos A. Gartner, Madeleine Nowak, Robert A. Koza	5
8	Identification of FBXO25‐interacting proteins using an integrated proteomics approach 2010 ·PROTEOMICS ·Felipe R. Teixeira, Sami Yokoo, Carlos A. Gartner, Adriana Oliveira Manfiolli, Munira Muhammad Abdel Baqui, (unknown), Ana Leticia Maragno, (unknown), Primal de Lanerolle, Jörg Kobarg, Steven P. Gygi, Marcelo D. Gomes	7
9	Enhancement of proteasome activity by a small-molecule inhibitor of USP14 breakdown → 2010 ·Nature ·Byung‐Hoon Lee, Min Jae Lee, Soyeon Park, Dong‐Chan Oh, Suzanne Elsasser, Ping-Chung Chen, Carlos A. Gartner, Nevena Dimova, John Hanna, Steven P. Gygi, Scott M. Wilson, Randall W. King, Daniel Finley	760
10	During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation 2009 ·The Journal of Cell Biology ·Shenhav Cohen, Jeffrey J. Brault, Steven P. Gygi, David J. Glass, David M. Valenzuela, Carlos A. Gartner, Esther Latres, Alfred L. Goldberg	472
11	Proteomic Analysis of GLUT4 Storage Vesicles Reveals LRP1 to Be an Important Vesicle Component and Target of Insulin Signaling 2009 ·Journal of Biological Chemistry ·Mark P. Jedrychowski, Carlos A. Gartner, Steven P. Gygi, Li Zhou, Joachim Herz, Konstantin V. Kandror, Paul F. Pilch	113
12	Assessing Enzyme Activities Using Stable Isotope Labeling and Mass Spectrometry 2007 ·Molecular & Cellular Proteomics ·Patrick A. Everley, Carlos A. Gartner, Wilhelm Haas, Alan Saghatelian, Joshua E. Elias, Benjamin F. Cravatt, Bruce R. Zetter, Steven P. Gygi	35
13	Catch-and-Release Reagents for Broadscale Quantitative Proteomics Analyses 2007 ·Journal of Proteome Research ·Carlos A. Gartner, Joshua E. Elias, Corey E. Bakalarski, Steven P. Gygi	45
14	Photochromic Agents as Tools for Protein Structure Study: Lapachenole Is a Photoaffinity Ligand of Cytochrome P450 3A4 2005 ·Biochemistry ·Carlos A. Gartner, Bo Wen, Jiandi Wan, Ralph S. Becker, (unknown), Steven P. Gygi, Sidney D. Nelson	15
15	Photoaffinity Ligands in the Study of Cytochrome P450 Active Site Structure 2003 ·Current Medicinal Chemistry ·Carlos A. Gartner	30
16	Co-purification of mitochondrial HSP70 and mature protein disulfide isomerase with a functional rat kidney high-Mr cysteine S-conjugate β-lyase33Abbreviations: AlaAT, alanine aminotransferase; AspAT, aspartate aminotransferase; BTC, benzothiazolyl-l-cysteine; CTFC, S-(2-chloro-1,1,2-trifluoroethyl)-l-cysteine; cyt, cytosolic; DCVC, S-(1,2-dichlorovinyl)-l-cysteine; DTT, dithiothreitol; GTK, glutamine transaminase K; mt, mitochondrial; NBT, nitroblue tetrazolium; PDI, protein disulfide isomerase; PLP, pyridoxal 5′-phosphate; PMS, phenazine methosulfate; PVDF, polyvinylidene difluoride; T3, 3,3′,5-triiodo-l-thyronine; TFA, trifluoroacetic acid; and TFEC, S-(1,1,2,2-tetrafluoroethyl)-l-cysteine 2001 ·Biochemical Pharmacology ·Arthur J.L. Cooper, Jianping Wang, Carlos A. Gartner, Sam A. Bruschi	22
17	Human Aromatase in High Yield and Purity by Perfusion Chromatography and Its Characterization by Difference Spectroscopy and Mass Spectrometry 2001 ·Protein Expression and Purification ·Carlos A. Gartner, (unknown), Allan E. Rettie, Sidney D. Nelson	14
18	Comprehensive Investigation of the Photophysical Behavior of Oligopolyfurans 2000 ·The Journal of Physical Chemistry A ·J. Sérgio Seixas de Melo, Fausto Elisei, Carlos A. Gartner, Gian Gaetano Aloisi, Ralph S. Becker	63
19	Subnanomolar quantification of caffeine's in vitro metabolites by stable isotope dilution gas chromatography–mass spectrometry 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·Kelly Regal, William N. Howald, (unknown), Carlos A. Gartner, Kent L. Kunze, Sidney D. Nelson	19
20	Long term effects of monthly low dose whole body irradiation on the glutathione status and thiobarbituric acid-reactive substances in different organs of male Wistar rats. 1990 ·PubMed ·Werner Siems, Carlos A. Gartner, (unknown), (unknown), Tilman Grune, Jill M. Schimke, (unknown), (unknown), G. B. Gerber	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact